BioMarin Pharmaceutical Inc.
DE ˙ DB ˙ US09061G1013
46,89 € ↓ -2,21 (-4,50%)
2026-06-02
AKTIENPREIS
SecurityDE:BM8 / BioMarin Pharmaceutical Inc.
InstitutionCaption Management, LLC
Latest Disclosed Ownership55,300 shares
Latest Disclosed Value $ 3,123,897
Caption Management, LLC ownership in BM8 / BioMarin Pharmaceutical Inc.

On May 15, 2026 - Caption Management, LLC filed a 13F-HR form disclosing ownership of 55,300 shares of BioMarin Pharmaceutical Inc. (DE:BM8) valued at $2,653,294 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 19,500 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 183.59% during the quarter. The current value of the position is $2,593,017 USD.

Caption Management, LLC has a history of taking positions in derivatives of the underlying security (BM8) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 209,500 of underlying shares valued at $11,834,655 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:BM8 / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 55,300 35,800 183.59 3,124 169.69 0.0182
2026-02-17 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,500 19,500 1,159 0.0079
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -27,300 -100.00 0 -100.00
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 27,300 27,300 1,919 0.0306
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -22,929 -100.00 0 -100.00
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 22,929 9,649 72.66 2,003 56.41 0.0304
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,280 13,280 1,280 0.0173
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -113,872 -100.00 0 -100.00
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 113,872 83,872 279.57 9,870 238.36 0.1748
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 30,000 30,000 2,917 0.0564
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -19,495 -100.00 0 -100.00
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,495 3,090 18.84 1,616 27.85 0.0223
2022-05-13 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,405 16,405 1,264 0.0152
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -25,399 -100.00 0 -100.00
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,399 24,997 6,218.16 1,918 5,380.00 0.0412
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 402 -29,898 -98.67 35 -98.48 0.0008
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 30,300 -36,688 -54.77 2,305 -72.10 0.0539
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 66,988 66,988 8,262 0.2752
2020-02-13 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -4,000 -100.00 0 -100.00
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,000 -12,500 -75.76 269 -80.98 0.0140
2019-08-13 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,500 -6,100 -26.99 1,414 -29.58 0.0712
2019-05-14 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 22,600 22,600 2,008 0.1107
2018-05-15 2018-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 0 -25,000 -100.00 0 -100.00
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,000 25,000 2,229 0.2311
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 52,000 103.92 2,816 101.00 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 25,500 -41.38 1,402 -54.44 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 43,500 -3.33 3,075 3.99 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 45,000 2,958 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 47,700 218.00 3,927 199.77 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 15,000 1,310 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 25,300 -89.65 2,239 -89.44 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 244,500 79.52 21,193 60.02 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 136,200 224.29 13,244 204.74 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 42,000 -30.00 4,347 -14.55 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 60,000 5,086 n/a n/a n/a
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-13 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 72,500 70.59 5,591 48.93 n/a n/a n/a
2022-02-11 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 42,500 3,754 n/a n/a n/a
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 140,400 -61.72 10,599 -67.05 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 366,800 68.18 32,165 93.91 n/a n/a n/a
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 218,100 230.45 16,588 103.78 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 66,000 -67.65 8,140 -52.78 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 204,000 41.57 17,237 41.47 n/a n/a n/a
2020-02-13 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 144,100 12,184 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-13 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 38,000 181.48 3,255 171.48 n/a n/a n/a
2019-05-14 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 13,500 -60.41 1,199 -58.70 n/a n/a n/a
2019-01-30 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 34,100 2,903 n/a n/a n/a
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 10,000 0.00 942 16.15 n/a n/a n/a
2018-05-15 2018-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Call 10,000 811 n/a n/a n/a
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 10,000 811 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 209,500 11,835 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 12,000 -72.41 660 -78.57 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 43,500 45.00 3,075 56.01 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 30,000 -29.41 1,972 -34.01 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 42,500 0.00 2,987 -14.63 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 42,500 -26.09 3,499 -30.33 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 57,500 10.58 5,022 0.18 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 52,000 31.98 5,014 43.80 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 39,400 -89.06 3,486 -88.84 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 360,300 353.78 31,231 304.53 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 79,400 -55.39 7,721 -58.09 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 178,000 78.00 18,421 117.31 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 100,000 -5.93 8,477 -3.77 n/a n/a n/a
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 106,300 21.49 8,809 30.62 n/a n/a n/a
2022-05-13 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 87,500 105.88 6,744 79.65 n/a n/a n/a
2022-02-11 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 42,500 3,754 n/a n/a n/a
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 121,400 -62.58 9,166 -67.78 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 324,400 80.22 28,446 107.74 n/a n/a n/a
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 180,000 176.92 13,693 70.80 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 65,000 116.67 8,017 216.38 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 30,000 -91.22 2,534 -91.22 n/a n/a n/a
2020-02-13 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 341,500 28,873 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-13 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 37,300 176.30 3,194 166.39 n/a n/a n/a
2019-05-14 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 13,500 1,199 n/a n/a n/a
2018-05-15 2018-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 40,000 3,566 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.